Stem Cell Theranostics

About:

Accelerating therapeutic discovery and enabling personalized medicine through the use of patient-derived cell models

Top Investors: National Science Foundation, Bill Marcus

Description:

Stem Cell Theranostics (SCT) is a biotechnology company dedicated to accelerating therapeutic discovery and enabling personalized medicine using patient-derived cell models.

Total Funding Amount:

$5.65M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2013-01-01

Contact Email:

rachel.bolger(AT)sctheranostics.com

Founders:

Andrew Lee

Number of Employees:

11-50

Last Funding Date:

2015-12-17

IPO Status:

Private

Industries: